Impact of imlifidase treatment on immunoglobulins in an HLA-hypersensitized lupus nephritis patient with anti-SSA/SSB antibodies after kidney transplantation: A case report

Bacterial recombinant cysteine protease Ides (imlifidase, Idefirix®, Hansa Biopharma) is used to prevent humoral transplant rejection in highly HLA-sensitized recipients, and to control IgG-mediated autoimmune diseases. We report the case of a 51 years old woman suffering from lupus nephritis with e...

Full description

Bibliographic Details
Main Authors: Jean Milhès, Olivier Marion, Benedicte Puissant, Caroline Carlé, Charlène Bouthemy, Arnaud Del Bello, Nassim Kamar, Yves Renaudineau, Nicolas Congy-Jolivet
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Translational Autoimmunity
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589909023000369

Similar Items